Gujarat Fluorochemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2026.
FLUOROCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Fluorochemicals reported its Q3 FY26 (quarter ended Dec 2025) unaudited results with standalone revenue of Rs. 1,026 Cr, down from Rs. 1,123 Cr in Q3 FY25. Standalone PAT stood at Rs. 127 Cr vs Rs. 153 Cr YoY. On a consolidated basis, Q3 revenue was Rs. 1,136 Cr and PAT was Rs. 102 Cr vs Rs. 126 Cr YoY. For the nine-month period, consolidated PAT grew about 31% YoY to Rs. 465 Cr, and consolidated operating margin expanded to 19.67% from 17.14% a year ago. The board recognised a one-time exceptional charge of Rs. 17 Cr related to the new Labour Codes. Mr. Vivek Jain was redesignated as Chairman and Managing Director after the passing of the previous chairman, and Deputy MD Dr. Bir Kapoor's remuneration was revised to Rs. 8 Cr per annum, subject to shareholder approval via postal ballot.
Mixed quarter — Q3 revenue and profits dipped YoY on a standalone basis, but nine-month consolidated profit and margins show healthy improvement, supported by the strong Chemicals segment. The Rs. 17 Cr exceptional item is a one-time cost and not a recurring concern. The leadership transition appears orderly and is unlikely to disrupt operations; shareholders will vote on the revised remuneration soon.